Advertisement

Topics

Companies Related to "HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies" [Most Relevant Company Matches] - Page: 2 RSS

04:24 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies" found in our extensive corporate database of over 50,000 company records.

Showing "Compatible Related Unrelated Donors With CD34 Enriched cell" Companies 26–50 of 3,000+

Relevant

Medistem Inc.

Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell being developed for critical limb ischemia and congestive heart failure. A pu...


Ocata Therapeutics, Inc.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocataâ...

Genetic Identification Services (GIS)

Genetic Identification Services (GIS) was established in 1994 to serve the agriculture, aquaculture, and wildlife ecology communities through the development and use of custom genetic markers for a wide variety of applications. GIS has extensive experience in the use of proprietary techniques to develop microsatellite-enriched libraries for academic, commercial, and government entities. GIS has al...


Ocata Therapeutics, Inc.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of regenerative ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocataâ...

One Cell Systems, Inc.

One Cell Systems is developing and marketing a family of single cell assays that rely on microencapsulation and flow cytometry. Technology underlying these products has been developed internally and licensed from MIT and other institutions and is protected by numerous issued and pending patents. Corporate headquarters are located in Cambridge, MA and include a Cell Screening Service Center eq...

San Diego Blood Bank

In December 1950, the San Diego Blood Bank (SDBB) was established through the support of the San Diego County Medical Society. SDBB’s mission is to provide the highest quality blood transfusion products and reference laboratory services to hospital partners throughout Southern California. We intend to further ensure the health of our community by simu...

Biochemed Corporation

Since 1979, Biochemed has specialized in the collection of rare and hard to find human biological specimens, primarily human serum and plasma used for research, development and manufacturing of diagnostic assays. Along with our active patient recruiting program, Biochemed has developed a network of physicians, group practices, and labs to locate study participants and donors, assuring us, a consta...

The National Marrow Donor Program

The National Marrow Donor Program (NMDP) is the global leader in providing marrow and umbilical cord blood transplants to patients with leukemia, lymphoma and other diseases. The nonprofit organization matches patients with donors, educates health care professionals and conducts research so more lives can be saved. The NMDP also operates Be The Match®, ...

Cryo-Cell International, Inc.

Based in Oldsmar, Florida, with over 200,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For mor...

Hycult Biotech Inc.

Hycult Biotech is a leader in the fields of immunology and cell biology, we develop, produce and market antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong ...

BioTime Inc.

BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime’s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime’s lead cell replacement product candidate is OpRegen®, a ret...

Document Storage Systems, Inc.

DSS, Inc. develops and supplies integrated enhancements to the Veterans Affairs VistA system and specializes in healthcare IT solutions that improve quality and productivity. The organization also designs applications that are compatible with the Indian Health Services RPMS, the Department of Defense’s healthcare systems and vxVistA.

Probably Relevant

Iceni BioDiscovery Limited

Iceni BioDiscovery Ltd is a product-focused biotechnology company that is developing commercial cell therapies for unmet medical needs. Iceni will initially target diabetes where recent success in transplantation has created a requirement for more human tissue than is available from organ donors. Diabetes is a major and growing disease that would substantially benefit from a new treatment to rest...

VIASPACE, Inc.

VIASPACE is a clean energy company providing products and technology for renewable and alternative energy that reduce or eliminate dependence on fossil and other high-pollutant energy sources. The Company provides raw material for cellulosic biofuels and develops and markets fuel cell cartridges, products and technology. VIASPACE subsidiary Direct Methanol Fuel Cell Corporation owns a portfolio of...

Dow Chemical Customer Information Group

We collect personal information from our visitors on a voluntary basis. Personal information may include name, title, company, address, phone number, email address, and other relevant data. Questions or comments submitted by visitors may also include personal information. We do not require personal information to obtain access to most of our site. We do, however, require it to download product inf...

Nature Cell

Nature Cell (KOSDAQ: 007390) is a high-tech bio enterprise that runs Stem Cells business. The company has exclusive rights for business of products developed by Biostar Stem Cell Research Institute. More information about Nature Cell can be found at www.naturecell.co.kr.

OptiCell Inc.

OptiCell is a new concept in cell culture devices that revolutionizes the cell culture process.OptiCell accommodates the full range of cellculture activities from cell growth and magnetic cell separation to transfection in a device with the footprint of a standard microtiter plate.OptiCell can also be used for the production of monoclonal antibodies, cytokines, and other secreted molecules.

Angiocrine Bioscience Inc.

Angiocrine Bioscience is a world-leader in genetically-modified endothelial cell-based technology (the E-CEL™ Technology) which has multiple applications in regenerative medicine. Angiocrine’s approach is unique and based on over twenty years of research in vascular and regenerative biology. We aim to transform the standards of medical practice t...

Imricor Medical Systems, Inc.

Imricor Medical Systems, Inc. is a privately held company committed to unlocking the potential of interventional cardiac magnetic resonance (iCMR) by delivering MR compatible systems and devices that allow physicians to perform cardiac ablations under real-time MRI-guidance.

Crown Philanthropic Solutions, LLC

Crown Philanthropic Solutions, LLC is the first solution in the Internet philanthropic space with an approach that can truly help mobilize the vast amounts of social capital that exist within the nation today. Crown recognized the pressure within foundations and financial services firms to respond to demands for increased transparency, functionality, and i...

AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), is a biotechnology company applying technology relating to cell immortality and regenerative biology, to aging and age-related diseases. The company has three initial areas of product development: pluripotent stem cell-derived brown adipocytes (AGEX-BAT1); vascular progenitors (AGEX-VAS...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies....

to-BBB

to-BBB is developing medicines for the treatment of devastating brain diseases. Our proprietary liposomal G-Technology® facilitates entry to the brain while simultaneously enabling sustained delivery of systemically administered therapeutics. Our technology has been shown to be compatible with approved as well as novel therapeutic entities. We have t...

Cytoshop

Cytoshop is devoted to provide life science research with the highest quality cytokines and other related molecules, such as interleukins, growth factors, chemokines, and developmental proteins related molecule products at the most competitive prices. The discovery of new molecules involved in cellular communication is occurring at a rapid pace. Over the past 2 years, in collaboration with ProSpec...

AVROBIO

AVROBIO is a clinical stage company developing transformative ex-vivo gene therapies targeting cancer and rare diseases. The catalyst for creating AVROBIO is to accelerate scientific breakthroughs related to the convergence of cell and gene therapies. The patient’s own cells can be effectively modified to deliver novel genes to treat serious debilitat...


More From BioPortfolio on "HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks